Product Information

PRISTIQ ER 100 MG TABLET is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $13.9483 per EA under NDC 00008122201. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the desvenlafaxine succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PRISTIQ ER 100 MG TABLET

desvenlafaxine succinate
$13.9483per EA
High Outlier

Strength

100 mg/1

NDC

00008122201

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

DESVENLAFAXINE SUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA021992

On Market Since

5/1/2008

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for PRISTIQ ER 100 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 141.2%. The table below summarizes its recorded NADAC range and movement.

Current price$13.9483 per EA
All-time high$13.9802 (Aug 14, 2024)
All-time low$5.7826 (Nov 28, 2013)
52-week high$13.9681
52-week low$13.9472
Median price$13.1972
Average price$11.8784
Largest weekly change+9.7% (Jan 8, 2014)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.1%

3Y

+0.2%

5Y

+2.8%

All

+141.2%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PRISTIQ ER 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRISTIQ ER 100 MG TABLET, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $13.9483 per EA (NDC 00008122201), effective Jun 24, 2026.

How has the price of PRISTIQ ER 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRISTIQ ER 100 MG TABLET has risen 141.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PRISTIQ ER 100 MG TABLET?

Since Nov 28, 2013, the NADAC for PRISTIQ ER 100 MG TABLET has ranged from a low of $5.7826 (Nov 28, 2013) to a high of $13.9802 (Aug 14, 2024), with a median of $13.1972 per EA.

Are there cheaper alternatives to PRISTIQ ER 100 MG TABLET?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PRISTIQ ER 100 MG TABLET, is $12.8531 per EA — about 8% below PRISTIQ ER 100 MG TABLET.

Who manufactures PRISTIQ ER 100 MG TABLET?

PRISTIQ ER 100 MG TABLET (NDC 00008122201) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.